UGA College of Pharmacy Continuing Education & Outreach

Role of Prostacyclin Derivatives in Pulmonary Arterial Hypertension

Co-Sponsor: MCG, UGA, SW Pharmacy

Contact Hours: 1.0

ACPE No: 0014-9999-10-043-L01-P

Activity Type: Knowledge Based

Release Date: March 03, 2010
Expiration Date: May 31, 2010

Learning Objectives

Upon completion of this activity the participant should be able to:
1. Describe the pathophysiology of pulmonary arterial hypertension.

2. Summarize clinical trials and guidelines for the use of synthetic prostacyclin and prostacyclin analogues in pulmonary arterial hypertension.

3. Compare and contrast prostacyclin treatment options for the treatment of pulmonary hypertension.

Faculty:

Christina Graham, Pharm.D.
PGY1 Pharmacy Resident
Medical College of Georgia

Computer Requirements for Online Courses
PC

Windows 2000 SE or greater
Flash Player Plugin 9.0 or later
Internet Explorer 6.0 or later OR Firefox 2.0 or later
Sound Card & Speakers
800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
Adobe Acrobat Reader for viewing PDF's

MAC

Mac OS 10.2.8
Flash Player Plugin 9.0 or greater
Safari 2.0 or above OR Firefox 2.0 or later
Sound Card & Speakers
800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
Adobe Acrobat Reader for viewing PDF's'

Acpelogo The University of Georgia College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.